
This fund typically commits a minimum of 80% of its net assets to common stocks of healthcare companies listed on U.S. exchanges. Its strategy also incorporates derivatives, mainly comprising futures contracts and options tied to individual securities, other futures, and various stock market indices. The fund has the discretion to make significant allocations to healthcare businesses with small to mid-sized market capitalizations. For international diversification within the healthcare sector, it may utilize American Depositary Receipts (ADRs), and it is also authorized to invest in U.S. government debt instruments.
Is RYHIX's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
No recent news available.